Inspire Medical Systems (INSP) drew fresh attention after its recent share price move, with the stock closing at $72.66. The shift invites a closer look at how current fundamentals align with recent market performance.
Recent trading in Inspire Medical Systems shows a mixed picture, with a 47.71% 90 day share price return pointing to short term momentum, while the year to date share price return has declined 21.25% and the 5 year total shareholder return is down 72.05%.
Scan how Inspire Medical Systems fits into the broader opportunity set by comparing it with a hand picked list of solid balance sheet and fundamentals (26 results).
After a sharp 90 day rebound yet weaker returns over longer periods, Inspire Medical Systems now sits at a crossroads. Has the meaningful part of the rerating already happened, or does valuation still leave room ahead?
Most Popular Narrative: 6.9% Overvalued
Inspire Medical Systems last closed at $72.66, above the most widely followed fair value estimate of $68.00 that applies a 7.54% discount rate and blends revenue, margin and multiple assumptions into a single view.
The view that Inspire Medical Systems is fairly valued and bearish suggests that the current share price already reflects expectations for improving margins, reimbursement clarity, and long-term OSA market penetration. This perspective implies limited potential for additional upside if execution aligns with current guidance.
See why 10 investors see Inspire Medical Systems as 7% overvalued.
Result: Fair Value of $68.00 (OVERVALUED)
Still, the slower Inspire V rollout tied to coding issues and WISeR disruption, along with legal scrutiny around alleged launch missteps, could pressure sentiment if setbacks deepen.
Find out about the key risks to this Inspire Medical Systems narrative.
Another View: Multiples Point To Underpricing
The fair value narrative pegs Inspire Medical Systems at $68.00 and labels the stock 6.9% overvalued. That sits awkwardly next to a P/E of 15.6x versus 26.1x for the US Medical Equipment industry and 36.9x across peers, with a fair ratio of 21.3x suggesting the market could easily lean higher. Is this gap a valuation cushion or a sign the market questions the durability of current earnings?
To pressure test that question against the earnings multiple, it helps to see how the current pricing compares on a full set of valuation checks See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If the split sentiment around Inspire Medical Systems leaves you unsure, treat that as your cue to look at the numbers directly and decide where you stand. Start with the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Inspire Medical Systems?
Do not stop your research with Inspire Medical Systems. Fresh ideas often appear where pricing, balance sheets, and dividends line up more cleanly than the headlines suggest.
- Target resilient cash generators by scanning a 30 high quality undervalued stocks that combines quality fundamentals with more modest pricing.
- Build steadier income streams by reviewing a 6 dividend fortresses built around higher yields and balance sheet support.
- Lower portfolio stress by filtering for a 30 resilient stocks with low risk scores that prioritises financial strength and reduced downside indicators.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com